Ken Fisher
IBB icon

Ken Fisher’s iShares Biotechnology ETF IBB Stock Holding History

Ken Fisher’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$383K Sell
2,268
-495
-18% -$84.6K ﹤0.01% 844
2025
Q4 		$466K Buy
2,763
+563
+26% +$91.4K ﹤0.01% 790
2025
Q3 		$318K Sell
2,200
-67
-3% -$9.14K ﹤0.01% 880
2025
Q2 		$287K Sell
2,267
-136
-6% -$16.7K ﹤0.01% 892
2025
Q1 		$307K Sell
2,403
-141
-6% -$19.1K ﹤0.01% 888
2024
Q4 		$336K Buy
2,544
+410
+19% +$57.6K ﹤0.01% 843
2024
Q3 		$311K Sell
2,134
-529
-20% -$76.5K ﹤0.01% 828
2024
Q2 		$366K Sell
2,663
-485
-15% -$64.7K ﹤0.01% 842
2024
Q1 		$432K Buy
+3,148
New +$430K ﹤0.01% 794
2023
Q4 		– Sell
-1,691
Closed -$207K – 1049
2023
Q3 		$207K Sell
1,691
-331
-16% -$42.1K ﹤0.01% 1014
2023
Q2 		$257K Buy
2,022
+199
+11% +$25.9K ﹤0.01% 979
2023
Q1 		$235K Sell
1,823
-5
-0.3% -$655 ﹤0.01% 956
2022
Q4 		$240K Buy
+1,828
New +$236K ﹤0.01% 949
2022
Q3 		– Sell
-2,007
Closed -$236K – 968
2022
Q2 		$236K Sell
2,007
-979
-33% -$116K ﹤0.01% 847
2022
Q1 		$389K Buy
2,986
+781
+35% +$102K ﹤0.01% 774
2021
Q4 		$337K Buy
2,205
+260
+13% +$40.3K ﹤0.01% 827
2021
Q3 		$314K Sell
1,945
-412
-17% -$69.3K ﹤0.01% 791
2021
Q2 		$386K Buy
2,357
+101
+4% +$15.6K ﹤0.01% 763
2021
Q1 		$340K Sell
2,256
-23
-1% -$3.65K ﹤0.01% 764
2020
Q4 		$345K Buy
2,279
+174
+8% +$24.9K ﹤0.01% 765
2020
Q3 		$285K Buy
2,105
+340
+19% +$46.1K ﹤0.01% 751
2020
Q2 		$241K Sell
1,765
-435
-20% -$55.5K ﹤0.01% 755
2020
Q1 		$237K Sell
2,200
-3,137
-59% -$361K ﹤0.01% 707
2019
Q4 		$643K Buy
5,337
+2,946
+123% +$329K ﹤0.01% 633
2019
Q3 		$238K Sell
2,391
-8,681
-78% -$909K ﹤0.01% 765
2019
Q2 		$1.21M Buy
+11,072
New +$1.18M ﹤0.01% 589
2019
Q1 		– Sell
-7,659
Closed -$739K – 824
2018
Q4 		$739K Buy
7,659
+5,772
+306% +$613K ﹤0.01% 616
2018
Q3 		$230K Buy
+1,887
New +$222K ﹤0.01% 751
2018
Q2 		– Sell
-2,708
Closed -$289K – 822
2018
Q1 		$289K Sell
2,708
-388
-13% -$43K ﹤0.01% 683
2017
Q4 		$331K Sell
3,096
-5,832
-65% -$623K ﹤0.01% 715
2017
Q3 		$993K Buy
8,928
+2,478
+38% +$265K ﹤0.01% 562
2017
Q2 		$667K Buy
+6,450
New +$635K ﹤0.01% 575
2017
Q1 		– Sell
-2,424
Closed -$214K – 744
2016
Q4 		$214K Sell
2,424
-1,827
-43% -$166K ﹤0.01% 679
2016
Q3 		$410K Buy
+4,251
New +$404K ﹤0.01% 593

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ken Fisher's IBB Position: Q1 2026 in Review

Ken Fisher reduced its iShares Biotechnology ETF (IBB) stake by 18% in Q1 2026, selling an estimated $84.6K and leaving 2,268 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #844.

Ken Fisher first reported a position in IBB in Q3 2016 and has held it in 34 quarters since. The position peaked at $1.21M in Q2 2019. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Ken Fisher held 2,268 shares of iShares Biotechnology ETF worth $383K as of Q1 2026.
  • Ken Fisher sold 495 iShares Biotechnology ETF shares in Q1 2026, an estimated $84.6K.
  • iShares Biotechnology ETF made up ﹤0.01% of Ken Fisher's portfolio in Q1 2026, its #844 holding.
  • Ken Fisher first reported a position in iShares Biotechnology ETF in Q3 2016 and has held it in 34 quarters since.
  • Ken Fisher's iShares Biotechnology ETF position peaked at $1.21M in Q2 2019.
  • 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.